The Ballad of TIGIT

mft_

A very nicely written article (and I don’t say that often!) And the overall premise is spot on: while it’s a shame that the drugs failed, it’s okay, because we want companies to be taking bets on targets that might result in the next big drug to save or prolong lives. > In 2026, a BMJ Oncology analysis would give a clinical name to what had happened: “herding.” The authors estimated that nearly 49,000 patients had been enrolled in anti-TIGIT trials by pharmaceutical companies, at a cost of more than $3 billion, all because their fellow pharmaceutical companies were doing the same thing This is also spot on. I’ve been in the room when people have been infected by this peculiar competitive mania. Rational science takes a backseat to FOMO. But it’s also somewhat understandable: the model we have relies on companies making money to continue to exist and invest in further research and drug development. So of course, they all wanted a slice of the pie, no matter how wrong this was in retrospect. It’s just how the current system works, and it’s the least bad (?) system we’ve yet evolved for such sharing out of resources.

kazinator

Anti-amyloid drugs work at reducing amyloid plaques. Only problem is that the idea that those plaques are the root cause for Alzheimer's was academic fraud.

epistasis

At the same time we see TIGIT targeted drugs failing, we are seeing the success of drugs against another white whale of cancer drug targets: KRAS. It's the most frequently mutated cancer activating gene out there, but has been declared "undruggable" for the 15-20 years I've been close enough to drug developers to have heard about it. Yet we're seeing clinical successes in recent trials with Revolution Medicine's daraxonrasib, and now there's blood in the water, with tons of new approaches going after it. The progress in biotech in the past few decades has been unbelievable , and lots of things that were considered impossible a few decades ago are now happening left and right. Whenever I hear that somebody thinks that technological progress has stopped, I just think that they've stopped looking in the right places for the huge advances that are going on.

y1n0

I enjoyed reading this. It gives some insight as to some reasons drugs can be expensive. Amortizing the cost of research and studies, which I think is well understood by many people, but this article presents it nicely. Especially when those costly studies don't pan out.

sijourneyweezer

I don’t know how you type out an acronym 40 times and not say what it is the letters stand for. Even if the author doesn’t think it’s worth knowing, which in the long run it isn’t, how could I know that without hearing what it stands for? I had to leave the page to look it up.

rad-b

A greatly written article! Really a masterclass of (1) getting the point across and (2) being emotionally engaging all the while not requiring me to have a PhD in pharmacology to understand it.

mrkeen

I love that failure is an option. Despite all the pressure from money, the science still won out. In a parallel universe, it would be hard to imagine that much money not altering the reported results significantly.